Vasodilator mechanism of intermedin/adrenomedullin-2 in anesthetized rats

Aly Mohamed Abdelrahman, Catherine Cheuk Ying Pang

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We examined whether the vasodepressor effect of intermedin/adrenomedullin- 2, a new member of the calcitonin gene-related peptide family, acted via activation of the nitric oxide/L-arginine pathway, the prostanoid pathway, or the opening of K+ channels. Intermedin/adrenomedullin-2 (0.3-30 nmol/kg) dose-dependently decreased mean arterial pressure (ED50 of 2.3±0.69 nmol/kg) and increased heart rate in anesthetized rats. The depressor effect of intermedin /adrenomedullin-2 (3 nmol/kg, ED70 dose) was unaffected by pretreatment with NG-nitro-L-arginine methyl ester (L-NAME, inhibitor of NO synthase, 50 mg/kg i.v.), indomethacin (cyclooxygenase inhibitor, 10 mg/kg i.v.), tetraethylammonium (TEA, non-specific K+-channel blocker; 60 mg/kg i.v.) or the respective vehicle. Pretreatment with mecamylamine (ganglionic blocker, 10 mg/kg i.v.) augmented the depressor response and abolished the tachycardic effect of intermedin/ adrenomedullin-2 (3 nmol/kg). Therefore, the depressor effect of intermedin /adrenomedullin-2 is not mediated via the nitric oxide/L-arginine pathway, production of prostanoids or opening of TEA-sensitive K+ channels, but is opposed by activity of the sympathetic nervous system. Its tachycardic effect is mediated via the baroreflex mechanism.

Original languageEnglish
Pages (from-to)43-46
Number of pages4
JournalProceedings of the Western Pharmacology Society
Volume50
Publication statusPublished - 2007

Fingerprint

Adrenomedullin
Vasodilator Agents
NG-Nitroarginine Methyl Ester
Prostaglandins
Arginine
Nitric Oxide
Ganglionic Blockers
Mecamylamine
Tetraethylammonium
Cyclooxygenase Inhibitors
Baroreflex
Calcitonin Gene-Related Peptide
Sympathetic Nervous System
Nitric Oxide Synthase
Indomethacin
Arterial Pressure
Heart Rate

ASJC Scopus subject areas

  • Pharmacology

Cite this

Vasodilator mechanism of intermedin/adrenomedullin-2 in anesthetized rats. / Abdelrahman, Aly Mohamed; Pang, Catherine Cheuk Ying.

In: Proceedings of the Western Pharmacology Society, Vol. 50, 2007, p. 43-46.

Research output: Contribution to journalArticle

@article{e7a57963c96e4b67bf5e8948e803d687,
title = "Vasodilator mechanism of intermedin/adrenomedullin-2 in anesthetized rats",
abstract = "We examined whether the vasodepressor effect of intermedin/adrenomedullin- 2, a new member of the calcitonin gene-related peptide family, acted via activation of the nitric oxide/L-arginine pathway, the prostanoid pathway, or the opening of K+ channels. Intermedin/adrenomedullin-2 (0.3-30 nmol/kg) dose-dependently decreased mean arterial pressure (ED50 of 2.3±0.69 nmol/kg) and increased heart rate in anesthetized rats. The depressor effect of intermedin /adrenomedullin-2 (3 nmol/kg, ED70 dose) was unaffected by pretreatment with NG-nitro-L-arginine methyl ester (L-NAME, inhibitor of NO synthase, 50 mg/kg i.v.), indomethacin (cyclooxygenase inhibitor, 10 mg/kg i.v.), tetraethylammonium (TEA, non-specific K+-channel blocker; 60 mg/kg i.v.) or the respective vehicle. Pretreatment with mecamylamine (ganglionic blocker, 10 mg/kg i.v.) augmented the depressor response and abolished the tachycardic effect of intermedin/ adrenomedullin-2 (3 nmol/kg). Therefore, the depressor effect of intermedin /adrenomedullin-2 is not mediated via the nitric oxide/L-arginine pathway, production of prostanoids or opening of TEA-sensitive K+ channels, but is opposed by activity of the sympathetic nervous system. Its tachycardic effect is mediated via the baroreflex mechanism.",
author = "Abdelrahman, {Aly Mohamed} and Pang, {Catherine Cheuk Ying}",
year = "2007",
language = "English",
volume = "50",
pages = "43--46",
journal = "Proceedings of the Western Pharmacology Society",
issn = "0083-8969",
publisher = "Western Pharmacology Society",

}

TY - JOUR

T1 - Vasodilator mechanism of intermedin/adrenomedullin-2 in anesthetized rats

AU - Abdelrahman, Aly Mohamed

AU - Pang, Catherine Cheuk Ying

PY - 2007

Y1 - 2007

N2 - We examined whether the vasodepressor effect of intermedin/adrenomedullin- 2, a new member of the calcitonin gene-related peptide family, acted via activation of the nitric oxide/L-arginine pathway, the prostanoid pathway, or the opening of K+ channels. Intermedin/adrenomedullin-2 (0.3-30 nmol/kg) dose-dependently decreased mean arterial pressure (ED50 of 2.3±0.69 nmol/kg) and increased heart rate in anesthetized rats. The depressor effect of intermedin /adrenomedullin-2 (3 nmol/kg, ED70 dose) was unaffected by pretreatment with NG-nitro-L-arginine methyl ester (L-NAME, inhibitor of NO synthase, 50 mg/kg i.v.), indomethacin (cyclooxygenase inhibitor, 10 mg/kg i.v.), tetraethylammonium (TEA, non-specific K+-channel blocker; 60 mg/kg i.v.) or the respective vehicle. Pretreatment with mecamylamine (ganglionic blocker, 10 mg/kg i.v.) augmented the depressor response and abolished the tachycardic effect of intermedin/ adrenomedullin-2 (3 nmol/kg). Therefore, the depressor effect of intermedin /adrenomedullin-2 is not mediated via the nitric oxide/L-arginine pathway, production of prostanoids or opening of TEA-sensitive K+ channels, but is opposed by activity of the sympathetic nervous system. Its tachycardic effect is mediated via the baroreflex mechanism.

AB - We examined whether the vasodepressor effect of intermedin/adrenomedullin- 2, a new member of the calcitonin gene-related peptide family, acted via activation of the nitric oxide/L-arginine pathway, the prostanoid pathway, or the opening of K+ channels. Intermedin/adrenomedullin-2 (0.3-30 nmol/kg) dose-dependently decreased mean arterial pressure (ED50 of 2.3±0.69 nmol/kg) and increased heart rate in anesthetized rats. The depressor effect of intermedin /adrenomedullin-2 (3 nmol/kg, ED70 dose) was unaffected by pretreatment with NG-nitro-L-arginine methyl ester (L-NAME, inhibitor of NO synthase, 50 mg/kg i.v.), indomethacin (cyclooxygenase inhibitor, 10 mg/kg i.v.), tetraethylammonium (TEA, non-specific K+-channel blocker; 60 mg/kg i.v.) or the respective vehicle. Pretreatment with mecamylamine (ganglionic blocker, 10 mg/kg i.v.) augmented the depressor response and abolished the tachycardic effect of intermedin/ adrenomedullin-2 (3 nmol/kg). Therefore, the depressor effect of intermedin /adrenomedullin-2 is not mediated via the nitric oxide/L-arginine pathway, production of prostanoids or opening of TEA-sensitive K+ channels, but is opposed by activity of the sympathetic nervous system. Its tachycardic effect is mediated via the baroreflex mechanism.

UR - http://www.scopus.com/inward/record.url?scp=48249135757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48249135757&partnerID=8YFLogxK

M3 - Article

C2 - 18605227

AN - SCOPUS:48249135757

VL - 50

SP - 43

EP - 46

JO - Proceedings of the Western Pharmacology Society

JF - Proceedings of the Western Pharmacology Society

SN - 0083-8969

ER -